The ALS Ice Bucket Challenge: one year later - ALS Societies across Canada announce historic investment in ALS research

MONTREAL, Nov. 9, 2015 /CNW Telbec/ - ALS Societies across Canada and the ALS Canada Research Program, in partnership with Brain Canada, will announce new investments to support ALS research across the country. This funding represents a ten-fold increase over historic investments, and was made possible by funds raised during the ALS Ice Bucket Challenge. This news commemorates the one year anniversary of ALS Canada and Brain Canada announcing their partnership to allocate dollars to advance ALS research in Canada.

The research being funded represents the most promising science in Canada and will aid in accelerating the development of effective treatments for those affected by ALS. ALS Canada and Brain Canada will announce the recipients of The Arthur J. Hudson Translational Team Grant (Hudson Grant), the single, largest ALS research competition in Canadian history.

When:	Thursday, November 19, 2015
	10:00 A.M. to 10:30 A.M.
	Media check-in begins at 9:45 A.M.
Where:	Montreal Neurological Institute and Hospital
	3801 University Street, Montréal
	The Jeanne Timmins Amphitheatre
Who:	Dr. Guy Rouleau, Director, Montreal Neurological Institute and Hospital
	Tammy Moore, CEO, ALS Canada
	Inez Jabalpurwala, President and CEO, Brain Canada Foundation
	Dr. Angela Genge, Director of the ALS Clinic, Montreal Neurological Institute and Hospital
	Dr. Christine Vande Velde, Associate Professor, Université de Montréal
	Carol Skinner, ALS Advocate

About ALS
ALS, (Amyotrophic Lateral Sclerosis) is a neurodegenerative disease where the cells in the body that control movement die. The "living wires" which connect a person's brain to their muscles degenerate, leading to a loss of mobility, changes or complete loss of speech and eventually take away the ability to breathe. ALS is a terminal disease that has no cure, and no effective treatment. Approx. 2,500 to 3,000 Canadians are living with ALS. The average lifespan is two to five years after diagnosis.

About ALS Canada Research Program
The ALS Canada Research Program aims to accelerate research impact through a comprehensive national program focused on translating scientific discoveries into treatments for ALS, and fostering Canada's strong and networked ALS research community to build capacity and collaboration. Support for the ALS Canada Research Program is made possible by the generosity of donors and the ALS Societies across Canada.

SOURCE ALS Canada

Justine Gagnepain, Edelman Public Relations, 514-315-1980, [email protected]